Better Health Care Tests, Faster

This article looks at some specific problems and solutions. Speeding up Test Development We’ve seen with COVID-19 how quickly a virus can evolve and how hard it is to design both tests and vaccinations that accommodate different variants. Virax Biolabs uses data from the World Health Organization and others to develop tests quickly. For instance, new viral variants tend to spread in the southern hemisphere before hitting the northern hemisphere in our Winter, so Virax can check existing data to prepare better tests for the North. The company is developing a T-cell diagnostics and profiling platform called Virax Immune, to predict an individual’s immune response to viral threats. Tomasz George, Ph.D., chief scientific officer, explained that testing for T-cells shows how well you’re protected from a given viral threat or after vaccinations. A good result might save you from needing a vaccine booster shot. Virax Immune is also planning to use AI to determine how well protected someone is from viral threats. They intend to collect information from the patient to help determine risk, such as whether the patient has pulmonary problems. They also plan to offer APIs to labs and public health organizations, delivering test results securely through an app along with advice about how to handle the risk. The company’s diagnostic platform, ViraxClear, distributes a range of highly accurate diagnostic tests globally. For Virax Immune, the company’s initial focus...
Source: EMR and HIPAA - Category: Information Technology Authors: Tags: Health IT Company Healthcare IT Hospital - Health System Interoperability CLIA COVID-19 Hydreight Immunexpress ixlayer Laboratories Labs Rolland Carlson Sepsis Sepsis Lab Tests Septicyte Shane Madden testing Tomasz George Source Type: blogs